BN
|
BusinessAI Desk3 views

Danone to Acquire Huel for €1 Billion as Health Nutrition Trends Surge

Danone has agreed to purchase Huel, a UK-based maker of vegan meal replacement shakes, for about 1 billion euros. The deal aims to capitalize on growing demand for health-centric nutrition products, partly fueled by the rise of weight-loss drugs. Huel, known for its plant-based offerings and celebrity endorsements, will leverage Danone's global reach and nutritional expertise. Both CEOs emphasized the merger's potential to address nutrient deficiencies through convenient options. Regulatory approval is pending, reflecting Danone's strategic pivot toward wellness-focused brands. This move highlights the food industry's adaptation to evolving consumer behaviors around health and sustainability.

Ad slot
Danone to Acquire Huel for €1 Billion as Health Nutrition Trends Surge

Danone, the French food and beverage giant, has announced plans to acquire Huel, a UK-based producer of vegan protein shakes and meal replacements, in a deal valued at approximately 1 billion euros. The acquisition responds to rising consumer demand for health-focused, convenient nutrition driven by trends like weight-loss drug use.

About Huel

Huel specializes in powdered, plant-based meal replacements marketed to time-constrained individuals seeking sustainable, nutrient-dense options. The company has attracted celebrity backers, including actor Idris Elba and entrepreneur Steven Bartlett.

Strategic Motivation

Danone CEO Antoine de Saint-Affrique highlighted the synergy between Huel's digital-first product range and Danone's global scale and nutritional expertise, calling it an opportunity in the "fast-growing nutritionally complete space." Huel CEO James McMaster stressed the brand's mission to combat common deficiencies in protein, fiber, and essential nutrients.

Transaction Details

  • The deal, reported by the Financial Times, is valued at around 1 billion euros ($1.15 billion), though Danone did not confirm the figure.
  • Regulatory approvals are required before completion.
  • Danone's portfolio, featuring Activia yoghurts, Alpro plant-based milk, and Aptamil infant formula, aligns with increasing health consciousness and GLP-1 drug adoption.

Market Context

The acquisition underscores a broader industry shift toward wellness-oriented products, as companies adapt to changing consumer preferences influenced by health trends and pharmaceutical developments like GLP-1 agonists for weight management.

Ad slot
Ad slot